🇺🇸 FDA
Patent

US 7192914

Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor

granted A61KA61K38/1709

Quick answer

US patent 7192914 (Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor) held by The Regents of the University of California expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/1709